Literature DB >> 11289751

Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment.

O Lawal1, A Agbakwuru, O S Olayinka, K Adelusola.   

Abstract

AIMS: The epidemiology of thyroid cancers in goitre endemic zones has not been recently reviewed, and changes being currently reported have been from studies in non-endemic areas. The aims of this study were to present the clinical pattern of thyroid malignancy in a goitre endemic area and identify recent changes, if any.
METHODS: The study was conducted at Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria between January 1983 and December 1993. Records of patients with nodular goitres treated with thyroidectomy were reviewed, and the clinical features, laboratory parameters, treatment, outcome and follow-up of histologically-proven malignant cases were studied.
RESULTS: Thirty-six of 279 (12.9%) patients, aged 13-85 years (mean)=43.7+/-14.7 years), carried malignant goitres, and most (80%) were young or middle-aged women. Of the well-differentiated cancers, follicular type was the most prevalent, being six- and 12-fold as frequent as papillary and medullary cancers (69%vs 11% and 5.6%), respectively. Lymphoma accounted for 5.6%, fibrosarcoma, 5.6% and anaplastic, 2.8%. No relationship was demonstrable between cancer type, duration of goitre and age at diagnosis (r=0.06 and 0.17, respectively).
CONCLUSIONS: Thyroid cancers afflict comparatively young women in our environment, and follicular cancer remains the predominant type, partly as a result of persisting dietary iodine deficiency. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289751     DOI: 10.1053/ejso.2000.1085

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  14 in total

1.  Clinical presentations of thyroid cancer patients with multiple primary cancers.

Authors:  J D Lin; K J Lin; T C Chao; C Hseuh; N M Tsang; B Y Huang
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

2.  Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.

Authors:  Panchagan Rama Kant Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Prasanta Kumar Pradhan; Sanjay Gambhir; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

Review 3.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

Authors:  Louise Davies; Luc G T Morris; Megan Haymart; Amy Y Chen; David Goldenberg; John Morris; Jennifer B Ogilvie; David J Terris; James Netterville; Richard J Wong; Gregory Randolph
Journal:  Endocr Pract       Date:  2015-06       Impact factor: 3.443

Review 4.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

5.  Changing patterns of thyroid carcinoma.

Authors:  B Dijkstra; R S Prichard; A Lee; L M Kelly; P P A Smyth; T Crotty; E W McDermott; A D K Hill; N O'Higgins
Journal:  Ir J Med Sci       Date:  2007-05-08       Impact factor: 1.568

6.  Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.

Authors:  X-G Zhu; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

7.  Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.

Authors:  H R Harach; Macarena Galíndez; Mónica Campero; G A Ceballos
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

8.  DID CHERNOBYL ACCIDENT CONTRIBUTE TO THE RISE OF THYROID CANCER IN TURKEY?

Authors:  A Kocakusak
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

9.  Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors.

Authors:  S-C Wu; S-Y Chi; C-S Rau; P-J Kuo; L-H Huang; Y-C Wu; C-J Wu; H-P Lin; C-H Hsieh
Journal:  J Endocrinol Invest       Date:  2021-03-01       Impact factor: 4.256

Review 10.  Impact of iodination on thyroid pathology in Africa.

Authors:  O E Okosieme
Journal:  J R Soc Med       Date:  2006-08       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.